Armata's presentation is scheduled for
More information, including a registration link, can be found here.
About
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, known as MSD outside of
Contact:
At Armata:
Tel: 310-665-2928 x234
Email: ir@armatapharma.com
(C) 2022 Electronic News Publishing, source